Program Strategy
- Program Strategy
  We provide comprehensive services to guide you through the development and execution of a program strategy, across all stages of development and life cycle management, for drugs, biologics, and medical devices.
  Overview
Clinical Trials
- Clinical Trials
  Our global solutions leverage decades of focused therapeutic expertise, strong site and investigator relationships and an insider’s understanding of international regulatory landscapes. Rho’s global team of experts ensure consistent trials—traditional, virtual, and hybrid—that run smarter and more efficiently.
Marketing Applications
- Marketing Applications
  Marketing application submissions, including NDAs, BLAs, and MAAs, are the culmination of years of research and the final hurdle before a product makes it to market. Let our integrated team of experts get your product across the finish line.
  Overview
Government Partnerships
Why Rho
- Why Rho
Resources
- Resources
Careers
- Careers

Webinar

Mapping Out Oncology Development: Filling Gaps and Avoiding Pitfalls

Kevin Barber, Ph.D.

Nine out of 10 clinical trials for new drugs fail; Oncology drugs have a 3.4 percent probability of succeeding. Still, cancer drugs can and are being commercialized. From 2003 to 2020, 124 oncology therapies were approved by FDA. What makes this possible? Knowing the key factors to consider at each juncture of development is critical to build the right roadmap for your product. In this webinar, you will learn how examining each step of drug development helps sponsors find success for cancer therapies. Topics include:

- How to fill gaps and avoid pitfalls of oncology drug development
- The importance of early phase planning, from optimum dosage to formulation
- The role of end-of-phase planning, such as regulatory feedback